Bayer

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Bayer and other ETFs, options, and stocks.

About BAYRY

Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health.

CEO

William N. Anderson

CEOWilliam N. Anderson

Employees

92,815

Employees92,815

Headquarters

Leverkusen, Nordrhein-Westfalen

HeadquartersLeverkusen, Nordrhein-Westfalen

Founded

1952

Founded1952

Employees

92,815

Employees92,815

BAYRY Key Statistics

Market cap

43.70B

Market cap43.70B

Price-Earnings ratio

-128.57

Price-Earnings ratio-128.57

Dividend yield

0.21%

Dividend yield0.21%

Average volume

441.97K

Average volume441.97K

High today

$11.16

High today$11.16

Low today

$11.05

Low today$11.05

Open price

$11.11

Open price$11.11

Volume

245.72K

Volume245.72K

52 Week high

$11.17

52 Week high$11.17

52 Week low

$4.96

52 Week low$4.96

BAYRY News

TipRanks 6h

Barclays upgrades Bayer to Overweight on possible litigation overhang resolution

As previously reported, Barclays upgraded Bayer (BAYRY) to Overweight from Equal Weight with a EUR 45 price target as the firm transferred coverage of European...

TipRanks 8h

Bayer upgraded to Overweight from Equal Weight at Barclays

Barclays analyst Charles Pitman-King upgraded Bayer (BAYRY) to Overweight from Equal Weight. Published first on TheFly – the ultimate source for real-time, mar...

TipRanks 2d

Bayer added to European Conviction List at Goldman Sachs

Goldman Sachs analysts added Bayer (BAYRY) to the firm’s European Conviction List as part of its monthly update. Goldman expects Bayer’s litigation overhang, wh...

Analyst ratings

52%

of 21 ratings

Buy

47.6%

Hold

52.4%

Sell

More BAYRY News

TipRanks 6d

Bayer Tests Talcid in Real-World Acid Rebound Study: What It Means for BAYRY Investors

Bayer AG (BAYRY) announced an update on their ongoing clinical study. Claim 70% Off TipRanks This Holiday Season Bayer AG is running a new observational study...